Fecal Microbiota Transplantation for Clostridium Difficile Infection
This trial is testing whether stool transplant can effectively treat recurrent C. diff infection by replenishing good bacteria in the colon.
- Clostridium Difficile Infection Recurrence
- Clostridium Difficile (C. diff) Infection
1 Primary · 0 Secondary · Reporting Duration: 12 months
Side Effects for
1 Treatment Group
Fecal Microbiota Transplantation
1 of 1
500 Total Participants · 1 Treatment Group
Primary Treatment: Fecal Microbiota Transplantation · No Placebo Group · N/A
Who is running the clinical trial?
Age Any Age · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the population size of participants in this experimental research?
"Affirmative. According to clinicaltrials.gov, this investigation is actively seeking participants. The trial was initially listed on January 16th 2014 and more recently updated on October 3rd 2021; it needs 500 people at one medical facility to contribute data." - Anonymous Online Contributor
Are there any vacancies available for participants of this research study?
"Indeed, this medical study is currently welcoming participants. Clinicaltrials.gov states that the trial was first published on January 16th 2014 and its most recent update occured on October 3rd 2021." - Anonymous Online Contributor